Anti-Heat Shock Protein 70 antibody levels are increased in myasthenia gravis and Guillain-Barré syndrome

Journal of Neuroimmunology

Volumn 225, Issue 1-2, 2010, Pages 180-183

  Helgeland, Geir ^a   Petzold, Axel ^b,c   Hoff, Jana Midelfart ^a,d   Gilhus, Nils Erik ^a,d   Plant, Gordon T ^e,f,g   Romi, Fredrik Robert ^d  

^a UNIVERSITY OF BERGEN   (Norway)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^e NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^f MOORFIELDS EYE HOSPITAL   (United Kingdom)

^g ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Heat Shock Protein 70; Myasthenia gravis; Ocular myasthenia gravis

Indexed keywords

CHOLINESTERASE INHIBITOR; HEAT SHOCK PROTEIN 70 ANTIBODY; IMMUNOSUPPRESSIVE AGENT; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; ANTIBODY BLOOD LEVEL; ARTICLE; CONTROLLED STUDY; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; MYASTHENIA GRAVIS; PRIORITY JOURNAL;

ADULT; AGED; ANTIBODIES; AUTOANTIBODIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GUILLAIN-BARRE SYNDROME; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MYASTHENIA GRAVIS; STATISTICS AS TOPIC; STATISTICS, NONPARAMETRIC;

EID: 77955657924     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2010.04.024     Document Type: Article

References (25)

1. Asea A., et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 2000, 6(4):435-442.
2. Birtas-Atesoglu E., et al. Serum levels of free heat shock protein 70 and anti-HSP70 are elevated in Behcet's disease. Clin. Exp. Rheumatol. 2008, 26(4 Suppl 50):S96-S98.
3. Bukau B., Horwich A.L. The Hsp70 and Hsp60 chaperone machines. Cell 1998, 92(3):351-366.
4. Conti-Fine B.M., Milani M., Kaminski H.J. Myasthenia gravis: past, present, and future. J. Clin. Invest. 2006, 116(11):2843-2854.
5. Gately M.K., et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Annu. Rev. Immunol. 1998, 16:495-521.
6. Hunt P.J., et al. Histocompatibility leucocyte antigens and closely linked immunomodulatory genes in autoimmune thyroid disease. Clin. Endocrinol. (Oxf) 2001, 55(4):491-499.
7. Leite M.I., et al. IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis. Brain 2008, 131(Pt 7):1940-1952.
8. Li Z., Menoret A., Srivastava P. Roles of heat-shock proteins in antigen presentation and cross-presentation. Curr. Opin. Immunol. 2002, 14(1):45-51.
9. Luchanok U., Kaminski H.J. Ocular myasthenia: diagnostic and treatment recommendations and the evidence base. Curr. Opin. Neurol. 2008, 21(1):8-15.
10. Millar D.G., et al. Hsp70 promotes antigen-presenting cell function and converts T-cell tolerance to autoimmunity in vivo. Nat. Med. 2003, 9(12):1469-1476.
11. Multhoff G. Heat shock protein 70 (Hsp70): membrane location, export and immunological relevance. Methods 2007, 43(3):229-237.
12. Munakata S., et al. The clinical significance of anti-heat shock cognate protein 71 antibody in myasthenia gravis. J. Clin. Neurosci. 2008, 15(2):158-165.
13. Pascale Ter Beek W., et al. The effect of plasma from muscle-specific tyrosine kinase myasthenia patients on regenerating endplates. Am. J. Pathol. 2009, 175(4):1536-1544.
14. Ratanachaiyavong S., et al. Heat shock protein 70 (HSP70) and complement C4 genotypes in patients with hyperthyroid Graves' disease. Clin. Exp. Immunol. 1991, 84(1):48-52.
15. Salvetti M., et al. The immune response to mycobacterial 70-kDa heat shock proteins frequently involves autoreactive T cells and is quantitatively disregulated in multiple sclerosis. J. Neuroimmunol. 1996, 65(2):143-153.
16. Tasneem S., Islam N., Ali R. Crossreactivity of SLE autoantibodies with 70kDa heat shock proteins of Mycobacterium tuberculosis. Microbiol. Immunol. 2001, 45(12):841-846.
17. Tebo A.E., et al. Antibody reactivity to heat shock protein 70 and inner ear-specific proteins in patients with idiopathic sensorineural hearing loss. Clin. Exp. Immunol. 2006, 146(3):427-432.
18. Tsan M.F., Gao B. Heat shock protein and innate immunity. Cell. Mol. Immunol. 2004, 1(4):274-279.
19. Vabulas R.M., et al. HSP70 as endogenous stimulus of the Toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 2002, 277(17):15107-15112.
20. Vincent A., Leite M.I. Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr. Opin. Neurol. 2005, 18(5):519-525.
21. Wang Y., et al. Stimulation of Th1-polarizing cytokines, C-C chemokines, maturation of dendritic cells, and adjuvant function by the peptide binding fragment of heat shock protein 70. J. Immunol. 2002, 169(5):2422-2429.
22. Yonekura K., et al. Prevalence of anti-heat shock protein antibodies in cerebrospinal fluids of patients with Guillain-Barre syndrome. J. Neuroimmunol. 2004, 156(1-2):204-209.
23. Yusuf N., et al. Heat shock proteins HSP27 and HSP70 are present in the skin and are important mediators of allergic contact hypersensitivity. J. Immunol. 2009, 182(1):675-683.
24. Zhang Z.Y., Zhang Z., Schluesener H.J. Toll-like receptor-2, CD14 and heat-shock protein 70 in inflammatory lesions of rat experimental autoimmune neuritis. Neuroscience 2009, 159(1):136-142.
25. Zlacka D., et al. Frequency of anti-hsp60, -65 and -70 antibodies in sera of patients with juvenile idiopathic arthritis. J. Autoimmun. 2006, 27(2):81-88.